National use of thrombolysis with alteplase for acute ischaemic stroke via telemedicine in Denmark: a model of budgetary impact and cost effectiveness

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Udgivelsesdato: 2008-null
Original languageEnglish
JournalC N S Drugs
Volume22
Issue number1
Pages (from-to)73-81
Number of pages8
ISSN1172-7047
Publication statusPublished - 2008

    Research areas

  • Aged, Brain Ischemia, Budgets, Cerebral Hemorrhage, Cost of Illness, Cost-Benefit Analysis, Denmark, Drug Costs, Drug Utilization, Female, Fibrinolytic Agents, Humans, Male, Models, Economic, Quality-Adjusted Life Years, Randomized Controlled Trials as Topic, Stroke, Telemedicine, Tissue Plasminogen Activator

See relations at Aarhus University Citationformats

ID: 15319405